Vontobel Holding
ABBV icon

Vontobel Holding’s AbbVie ABBV Stock Holding History

Vontobel Holding’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.9M Buy
198,110
+27,196
+16% +$5.85M 0.16% 132
2026
Q1 		$37.2M Buy
170,914
+25,190
+17% +$5.59M 0.13% 151
2025
Q4 		$33.3M Buy
145,724
+2,988
+2% +$681K 0.1% 158
2025
Q3 		$33M Buy
142,736
+396
+0.3% +$80.6K 0.1% 145
2025
Q2 		$26.4M Buy
142,340
+7,900
+6% +$1.47M 0.08% 163
2025
Q1 		$28.2M Buy
134,440
+3,841
+3% +$747K 0.1% 138
2024
Q4 		$23.2M Sell
130,599
-4,079
-3% -$750K 0.08% 148
2024
Q3 		$26.6M Buy
134,678
+2,087
+2% +$390K 0.09% 145
2024
Q2 		$22.7M Sell
132,591
-35,099
-21% -$5.81M 0.07% 149
2024
Q1 		$30.5M Sell
167,690
-20,138
-11% -$3.47M 0.24% 107
2023
Q4 		$29.1M Sell
187,828
-2,895
-2% -$422K 0.24% 107
2023
Q3 		$28.4M Sell
190,723
-20,233
-10% -$2.97M 0.26% 98
2023
Q2 		$28.4M Sell
210,956
-91
-0% -$13.3K 0.25% 99
2023
Q1 		$33.6M Buy
211,047
+21,056
+11% +$3.22M 0.31% 86
2022
Q4 		$30.8M Sell
189,991
-15,931
-8% -$2.44M 0.31% 86
2022
Q3 		$27.6M Buy
205,922
+38,043
+23% +$5.46M 0.32% 81
2022
Q2 		$25.9M Sell
167,879
-7
-0% -$1.07K 0.28% 84
2022
Q1 		$27.5M Sell
167,886
-64,487
-28% -$9.37M 0.24% 97
2021
Q4 		$31.6M Sell
232,373
-27,381
-11% -$3.23M 0.26% 86
2021
Q3 		$28M Buy
259,754
+33,389
+15% +$3.82M 0.25% 90
2021
Q2 		$25.4M Sell
226,365
-8,146
-3% -$917K 0.22% 97
2021
Q1 		$25.4M Buy
234,511
+53,279
+29% +$5.7M 0.19% 78
2020
Q4 		$19.4M Buy
+181,232
New +$17.4M 0.13% 117

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vontobel Holding's ABBV Position: Q2 2026 in Review

Vontobel Holding increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $5.85M and bringing the position to 198,110 shares worth $49.9M. The position accounts for 0.16% of the portfolio, ranked #132.

Vontobel Holding first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vontobel Holding held 198,110 shares of AbbVie worth $49.9M as of Q2 2026.
  • Vontobel Holding bought 27,196 AbbVie shares in Q2 2026, an estimated $5.85M.
  • AbbVie made up 0.16% of Vontobel Holding's portfolio in Q2 2026, its #132 holding.
  • Vontobel Holding first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.